AXSOME THERAPEUTICS INC. - COMMON STOCK

Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Hikma Pharmaceuticals USA

05 Mar 2025 06:00:00 By Nasdaq GlobeNewswire

Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-05 in Alzheimer’s Disease Agitation Supporting NDA Submission

03 Mar 2025 06:00:00 By Nasdaq GlobeNewswire

Axsome Therapeutics to Participate in Upcoming Investor Conferences

26 Feb 2025 06:00:00 By Nasdaq GlobeNewswire

Axsome Therapeutics Announces SYMBRAVO® (meloxicam and rizatriptan) Achieves Primary Endpoint in the EMERGE Phase 3 Trial in Migraine Patients Experiencing Inadequate Response to Oral CGRP Inhibitors

24 Feb 2025 06:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

21 Feb 2025 10:16:01 By NetDania Notify

Axsome Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

18 Feb 2025 06:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

11 Feb 2025 09:02:00 By NetDania Notify

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

10 Feb 2025 08:45:13 By NetDania Notify

Axsome Therapeutics Announces Settlement Agreement Resolving AUVELITY® (dextromethorphan HBr – bupropion HCl) Patent Litigation

10 Feb 2025 06:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

06 Feb 2025 08:55:37 By NetDania Notify

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

05 Feb 2025 08:45:07 By NetDania Notify

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

04 Feb 2025 09:19:52 By NetDania Notify

Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought Leader

31 Jan 2025 06:00:00 By Nasdaq GlobeNewswire

Axsome Therapeutics Announces FDA Approval of SYMBRAVO® (meloxicam and rizatriptan) for the Acute Treatment of Migraine with or without Aura in Adults

30 Jan 2025 14:45:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

30 Jan 2025 08:45:15 By NetDania Notify

NetDania - New 12 months High: AXSOME THERAPEUTICS INC. - COMMON STOCK

27 Jan 2025 09:08:34 By NetDania Notify

Axsome Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18

22 Jan 2025 06:00:00 By Nasdaq GlobeNewswire

Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue

13 Jan 2025 06:00:01 By Nasdaq GlobeNewswire

Axsome Therapeutics Announces Successful Completion and Results of Phase 3 Clinical Program of AXS-05 in Alzheimer’s Disease Agitation

30 Dec 2024 06:00:00 By Nasdaq GlobeNewswire

Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in ENCORE Long-Term Phase 3 Trial in Narcolepsy

26 Nov 2024 06:00:00 By Nasdaq GlobeNewswire